Samsrita Labs
BSE: 539267 | NSE: | ISIN: INE579N01018 | SECTOR: Healthcare FacilitiesOpen
17.79High
17.79Low
16.30Prev Close
17.40P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
0.25BVolume
12.50KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Promoter Pledge Holding - 2.7%
| Promoter Name | No of Shares | Percentage |
|---|---|---|
| KRISHNAM RAJU KALIDINDI | 4,00,000 | 2.70% |
Company Description
- Healthcare Facilities
BSE
539267NSE
ISIN
INE579N01018
Samsrita Labs Ltd is an India-based biopharma company. The Company is engaged activities, such as trading, exports and imports, manufacturing of bulk drugs, APIs, Specialty drugs, research and development (R&D) through joint ventures or associations or mergers or by its own. It has established platforms in the areas of stem cell research and therapy, new drug discovery, molecular prognosis and diagnostics services, CRO, stem cell focused super specialty hospital, RNA interference technology and medical devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson's disease, non-alcoholic steatohepatitis, neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease.
Company Officers
Kalidindi Raju
Executive Chairman of the BoardK. N. V. Kumar
Chief Financial Officer